Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer

By                        

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1051-1058

Spandidos Publications

Access to resources Recommend Favorite

Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope

By Thorn Mette   Wang Mingjun   Kløverpris Henrik   Schmidt Esben   Fomsgaard Anders   Wenandy Lynn   Berntsen Annika   Brunak Søren   Buus Søren   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1755-1763

Springer Publishing Company

Access to resources Recommend Favorite

The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2

By Mitchell Malcolm   Lund Teri   Sewell Andrew   Marincola Francesco   Paul Elyse   Schroder Kim   Wilson Darcy   Kan-Mitchell June  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 287-301

Springer Publishing Company

Access to resources Recommend Favorite

Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes

By Jaramillo André  

Breast Cancer Research and Treatment, Vol. 88, Iss. 1, 2004-11 ,pp. : 29-41

Springer Publishing Company

Access to resources Recommend Favorite

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

By Wobser Marion   Keikavoussi Petra   Kunzmann Volker   Weininger Markus   Andersen Mads   Becker Juergen  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1294-1298

Springer Publishing Company

Access to resources Recommend Favorite